HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of drospirenone (3 mg) with ethinyl estradiol (30 mcg) containing pills on ovarian blood flows in women with polycystic ovary syndrome: a case controlled study.

AbstractOBJECTIVE:
To evaluate whether oral contraceptive pill (OCP) therapy has any effects on ovarian stromal blood flow by using pulsed and color Doppler at the end of 3 months follow-up period of OCP-users and non-users with or without polycystic ovary syndrome (PCOS).
STUDY DESIGN:
200 patients were included in the study. The patients were designed into four groups as follows; Group 1: PCOS patients that received OCP containing 30 mcg ethinyl estradiol (EE) plus 3mg drospirenone for 3 months (DRP n=50); Group 2: PCOS patients that received no medication (n=50); Group 3: Healthy controls that received OCP (EE plus DRP) (n=50); Group 4: healthy controls that received no medication (n=50). Resistance index (RI) and pulsatility index (PI) of both ovarian arteries, hormonal, anthropometric and biochemical parameters were assessed before and after 3 months.
RESULTS:
There was a significant increament in RI and PI of both ovarian arteries in healthy controls (Group 3) and in women with PCOS (Group 1) who received OCP (p<0.001). The increment rate in both Doppler parameters were significantly higher in women with PCOS (Group 1) than healthy controls (Group 3) (p<0.001). Whereas RI and PI values of both ovaries remained unchanged in all untreated women with or without PCOS (Groups 2 and 4).
CONCLUSION:
OCP therapy reduced ovarian vascularization in both PCOS and healthy users after 3 months of therapy and this decrease is especially noticeable in women with PCOS.
AuthorsEmre Okyay, Funda Gode, Ferruh Acet, Taylan Bodur, Erkan Cagliyan, Ceyda Sahan, Cemal Posaci, Bulent Gulekli
JournalEuropean journal of obstetrics, gynecology, and reproductive biology (Eur J Obstet Gynecol Reprod Biol) Vol. 180 Pg. 93-9 (Sep 2014) ISSN: 1872-7654 [Electronic] Ireland
PMID25063905 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Androstenes
  • Contraceptives, Oral, Combined
  • drospirenone and ethinyl estradiol combination
  • Ethinyl Estradiol
Topics
  • Adult
  • Androstenes (pharmacology)
  • Case-Control Studies
  • Contraceptives, Oral, Combined (pharmacology)
  • Ethinyl Estradiol (pharmacology)
  • Female
  • Humans
  • Ovary (blood supply, diagnostic imaging)
  • Polycystic Ovary Syndrome (blood supply, diagnostic imaging, drug therapy)
  • Prospective Studies
  • Regional Blood Flow (drug effects)
  • Ultrasonography, Doppler, Color
  • Ultrasonography, Doppler, Pulsed
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: